Preparing for renal replacement therapy in patients with the ebola virus disease

Blood Purification

Volumn 38, Issue 3-4, 2014, Pages 276-285

  Faubel, Sarah ^a   Franch, Harold ^b   Vijayan, Anitha ^c   Barron, Michelle A ^d   Heung, Michael ^e   Liu, Kathleen D ^f   Koyner, Jay L ^g   Conner, Michael J ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c WASHINGTON UNIVERSITY   (United States)

^d UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g UNIVERSITY OF CHICAGO   (United States)

Author keywords

Biocontainment facility; Ebola virus disease; Renal replacement therapy

Indexed keywords

ANTICOAGULANT AGENT;

ANTICOAGULANT THERAPY; CLINICAL PROTOCOL; CRITICAL ILLNESS; EBOLA HEMORRHAGIC FEVER; EBOLAVIRUS; EXPERIENCE; HEALTH CARE DELIVERY; HEALTH CARE PERSONNEL; HUMAN; LABORATORY TEST; MATERIALS HANDLING; MEDICAL DEVICE; NEPHROLOGY; OUTPATIENT DEPARTMENT; PATIENT CARE PLANNING; POINT OF CARE TESTING; PRACTICE GUIDELINE; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; REVIEW; SCREENING; TREATMENT OUTCOME; TREATMENT RESPONSE; VIRUS TRANSMISSION; WASTE DISPOSAL; ACUTE KIDNEY INJURY; AFRICA; ARTIFICIAL VENTILATION; BODY FLUID; COMPLICATION; CONTRAINDICATIONS; DEVELOPED COUNTRY; DEVICES; DIFFERENTIAL DIAGNOSIS; DISEASE OUTBREAKS; DISEASE TRANSMISSION; EPIDEMIOLOGY; ETHICS; HAZARDOUS WASTE; HEMORRHAGIC FEVER, EBOLA; INTENSIVE CARE; ISOLATION AND PURIFICATION; KIDNEY TUBULAR NECROSIS, ACUTE; MASS SCREENING; MEDICAL DEVICE CONTAMINATION; PATHOGENICITY; PATIENT CARE; PREVENTION AND CONTROL; PROCEDURES; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TRANSMISSION; TRAVEL; VIROLOGY; WATER-ELECTROLYTE IMBALANCE;

ACUTE KIDNEY INJURY; AFRICA; ANTICOAGULANTS; BODY FLUIDS; CONTAINMENT OF BIOHAZARDS; CRITICAL CARE; DELIVERY OF HEALTH CARE; DEVELOPED COUNTRIES; DIAGNOSIS, DIFFERENTIAL; DISEASE OUTBREAKS; EBOLAVIRUS; EQUIPMENT CONTAMINATION; HEMORRHAGIC FEVER, EBOLA; HUMANS; INFECTIOUS DISEASE TRANSMISSION, PATIENT-TO-PROFESSIONAL; KIDNEY TUBULAR NECROSIS, ACUTE; MASS SCREENING; PATIENT CARE TEAM; PATIENT ISOLATION; PRACTICE GUIDELINES AS TOPIC; RENAL REPLACEMENT THERAPY; RESPIRATION, ARTIFICIAL; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TRAVEL; WATER-ELECTROLYTE IMBALANCE;

EID: 84929655969     PISSN: 02535068     EISSN: 14219735     Source Type: Journal    
DOI: 10.1159/000371530     Document Type: Review

References (28)

1. Dixon MG, Schafer IJ. Ebola viral disease outbreak-West Africa, 2014. MMWR Morb Mortal Wkly Rep 2014; 63: 548-551.
2. World Health Organization: Geographic distribution of Ebola virus disease outbreaks in humans and animals-2014. http://www.who.int/csr/disease/ebola/global-ebolaout breakrisk-20140818-1.png?ua=1 (accessed December 2, 2014).
3. World Health Organization: Ebola virus disease, Fact sheet Number 103. http://www.who.int/mediacentre/factsheets/fs103/en/. (accessed December 2, 2014).
4. World Health Organization: Ebola response roadmap situation report. http://www.who. int/csr/disease/ebola/situation-reports/en/. (accessed December 17, 2014).
5. Fowler RA, Fletcher T, Fischer WA 2nd, et al. Caring for critically ill patients with Ebola virus disease. Perspectives from West Africa. Am J Respir Crit Care Med 2014; 190: 733-737.
6. Lyon GM, Mehta AK, Varkey JB, et al. Clinical care of two patients with Ebola virus disease in the United States. N Engl J Med 2014;37: 2402-2409.
7. Fletcher TE, Fowler RA, Beeching NJ. Understanding organ dysfunction in Ebola virus disease. Intensive Care Med 2014; 40: 1936-1939.
8. Rollin PE, Bausch DG, Sanchez A. Blood chemistry measurements and D-Dimer levels associated with fatal and nonfatal outcomes in humans infected with Sudan Ebola virus. J Infect Dis 2007; 196(suppl 2):S364-S371.
9. Connor MJ Jr, Kraft C, Mehta AK, et al. Successful delivery of RRT in Ebola virus disease. J Am Soc Nephrol 2015;26:31-37.
10. Martines RB, Ng DL, Greer PW, Rollin PE, Zaki SR. Tissue and cellular tropism, pathology and pathogenesis of Ebola and Marburg viruses. J Pathol 2014; 253: 153-174.
11. Kreuels B, Wichmann D, Emmerich P, et al. A case of severe Ebola virus infection complicated by gram-negative septicemia. N Engl J Med 2014; 371: 2394-2401.
12. Bausch DG, Towner JS, Dowell SF, et al. Assessment of the risk of Ebola virus transmission from bodily fluids and fomites. J Infect Dis 2007; 196(suppl 2):S142-S147.
13. Feldmann H, Geisbert TW. Ebola haemorrhagic fever. Lancet 2011; 377: 849-862.
14. Rowe AK, Bertolli J, Khan AS, et al; Commission de Lutte contre les Epidemies a Kikwit: Clinical, virologic, and immunologic followup of convalescent Ebola hemorrhagic fever patients and their household contacts, Kikwit, Democratic Republic of the Congo. J Infect Dis 1999; 179(suppl 1):S28-S35.
15. Towner JS, Rollin PE, Bausch DG, et al. Rapid diagnosis of Ebola hemorrhagic fever by reverse transcription-PCR in an outbreak setting and assessment of patient viral load as a predictor of outcome. J Virol 2004; 78: 4330-4341.
16. Simon V, Ho DD, Abdool Karim Q. HIV/ AIDS epidemiology, pathogenesis, prevention, and treatment. Lancet 2006; 368: 489-504.
17. Smith PW, Anderson AO, Christopher GW, et al. Designing a biocontainment unit to care for patients with serious communicable diseases: a consensus statement. Biosecur Bioterror 2006; 4: 351-365.
18. Hill CE, Burd EM, Kraft CS, et al. Laboratory test support for ebola patients within a highcontainment facility. Lab Med 2014; 45:e109-e111.
19. Centers for Disease Control and Prevention: Interim guidance for environmental infection control in hospitals for Ebola virus. http://www.cdc.gov/vhf/ebola/hcp/environmentalinfection-control-in-hospitals.html. (accessed December 2, 2014).
20. Centers for Disease Control and Prevention: Recommendations for safely performing Acute Hemodialysis in Patients with Ebola Virus Disease in U.S. Hospitals. http://www.cdc.gov/vhf/ebola/hcp/guidance-dialysis. html. (accessed October 23, 2014).
21. Callegari J, Antwi S, Wystrychowski G, Zukowska-Szczechowska E, Levin NW, Carter M. Peritoneal dialysis as a mode of treatment for acute kidney injury in sub-Saharan Africa. Blood Purif 2013; 36: 226-230.
22. Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney Int Suppl 2012; 2: 1-138.
23. van de Wetering J, Westendorp RG, van der Hoeven JG, Stolk B, Feuth JD, Chang PC. Heparin use in continuous renal replacement procedures: the struggle between filter coagulation and patient hemorrhage. J Am Soc Nephrol 1996; 7: 145-150.
24. Tolwani AJ, Wille KM. Anticoagulation for continuous renal replacement therapy. Semin Dial 2009; 22: 141-145.
25. Biancofiore G, Esposito M, Bindi L, et al. Regional filter heparinization for continuous veno-venous hemofiltration in liver transplant recipients. Minerva Anestesiol 2003; 69: 527-534; discussion 534-538.
26. Clark WR, Turk JE, Kraus MA, Gao D. Dose determinants in continuous renal replacement therapy. Artif Organs 2003; 27: 815-820.
27. Davies HT, Leslie G, Pereira SM, Webb SA. A randomized comparative crossover study to assess the affect on circuit life of varying predilution volume associated with CVVH and CVVHDF. Int J Artif Organs 2008; 31: 221-227.
28. Hofmann CL, Fissell WH. Middle-molecule clearance at 20 and 35 ml/kg/h in continuous venovenous hemodiafiltration. Blood Purif 2010; 29: 259-263.